EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss

Xiaojing Qiao, Xiuju Wu iD, Yan Zhao, Yang Yang, Li Zhang iD, Xinjiang Cai iD, Jocelyn A Ma, Jaden Ji, Karen Lyons, Kristina I Boström, Yucheng Yao

Cells · 08.07.2023 · 12 (14) · 1810

DOI: 10.3390/cells12141810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 08.07.2023. Verfasst von Xiaojing Qiao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Glucocorticoids, Bone Diseases, Metabolic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid-induced bone loss is a toxic effect of long-term therapy with glucocorticoids resulting in a significant increase in the risk of fracture. Here, we find that glucocorticoids reciprocally convert osteoblast-lineage cells into endothelial-like cells. This is confirmed by lineage tracing showing the induction of endothelial markers in osteoblast-lineage cells following glucocorticoid treatment. Functional studies show that osteoblast-lineage cells isolated from glucocorticoid-treated mice lose their capacity for bone formation but simultaneously improve vascular repair. We find that the glucocorticoid receptor directly targets Foxc2 and Osterix, and the modulations of Foxc2 and Osterix drive the transition of osteoblast-lineage cells to endothelial-like cells. Together, the results suggest that glucocorticoids suppress osteogenic capacity and cause bone loss at least in part through previously unrecognized osteoblast–endothelial transitions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsBone Diseases, MetabolicMiceAnimalsOsteoblastsOsteogenesis

Stichwörter der Autor:innen

bone lossendothelial-like cellsglucocorticoidosteoblasttransition

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
  • Department of Molecular, Cell & Developmental Biology at UCLA, Los Angeles, CA 90095, USA.
  • The Molecular Biology Institute at UCLA, Los Angeles, CA 90095, USA.

ORCID-Profile: Xiuju Wu, Li Zhang, Xinjiang Cai

Förderung

  • NHLBI NIH HHS
  • NINDS NIH HHS
  • NIH

Zitieren

APA

Qiao, X., Wu, X., Zhao, Y., Yang, Y., Zhang, L., Cai, X., Ma, J. A., Ji, J., Lyons, K., Boström, K. I., & Yao, Y. (2023). Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss. Cells, 12(14), 1810. https://doi.org/10.3390/cells12141810

Vancouver

Qiao X, Wu X, Zhao Y, Yang Y, Zhang L, Cai X, et al. Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss. Cells. 2023;12(14):1810. doi:10.3390/cells12141810

BibTeX
@article{Qiao2023,
  author = {Qiao, Xiaojing and Wu, Xiuju and Zhao, Yan and Yang, Yang and Zhang, Li and Cai, Xinjiang and Ma, Jocelyn A and Ji, Jaden and Lyons, Karen and Boström, Kristina I and Yao, Yucheng},
  title = {Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {14},
  pages = {1810},
  doi = {10.3390/cells12141810}
}
Kostenlos starten →